197 related articles for article (PubMed ID: 20460528)
1. A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias.
Parameswaran R; Müschen M; Kim YM; Groffen J; Heisterkamp N
Cancer Res; 2010 Jun; 70(11):4346-56. PubMed ID: 20460528
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma.
Onda K; Iijima K; Katagiri YU; Okita H; Saito M; Shimizu T; Kiyokawa N
Int J Hematol; 2010 Jun; 91(5):808-19. PubMed ID: 20428981
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional and post-transcriptional mechanisms of BAFF-receptor dysregulation in human B lineage malignancies.
Mihalcik SA; Tschumper RC; Jelinek DF
Cell Cycle; 2010 Dec; 9(24):4884-92. PubMed ID: 21099364
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin.
Parameswaran R; Yu M; Lyu MA; Lim M; Rosenblum MG; Groffen J; Heisterkamp N
Leukemia; 2012 Aug; 26(8):1786-96. PubMed ID: 22373785
[TBL] [Abstract][Full Text] [Related]
5. Effector-mediated eradication of precursor B acute lymphoblastic leukemia with a novel Fc-engineered monoclonal antibody targeting the BAFF-R.
Parameswaran R; Lim M; Fei F; Abdel-Azim H; Arutyunyan A; Schiffer I; McLaughlin ME; Gram H; Huet H; Groffen J; Heisterkamp N
Mol Cancer Ther; 2014 Jun; 13(6):1567-77. PubMed ID: 24825858
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23.
Debnath I; Roundy KM; Weis JJ; Weis JH
Mol Immunol; 2007 Mar; 44(9):2388-99. PubMed ID: 17140663
[TBL] [Abstract][Full Text] [Related]
7. DYRK1a mediates BAFF-induced noncanonical NF-κB activation to promote autoimmunity and B-cell leukemogenesis.
Li Y; Xie X; Jie Z; Zhu L; Yang JY; Ko CJ; Gao T; Jain A; Jung SY; Baran N; Konopleva MY; Cheng X; Sun SC
Blood; 2021 Dec; 138(23):2360-2371. PubMed ID: 34255829
[TBL] [Abstract][Full Text] [Related]
8. BAFF controls neural cell survival through BAFF receptor.
Tada S; Yasui T; Nakatsuji Y; Okuno T; Koda T; Mochizuki H; Sakoda S; Kikutani H
PLoS One; 2013; 8(7):e70924. PubMed ID: 23923031
[TBL] [Abstract][Full Text] [Related]
9. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.
Moreaux J; Legouffe E; Jourdan E; Quittet P; Rème T; Lugagne C; Moine P; Rossi JF; Klein B; Tarte K
Blood; 2004 Apr; 103(8):3148-57. PubMed ID: 15070697
[TBL] [Abstract][Full Text] [Related]
10. Role of BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma.
Yang S; Li JY; Xu W
Crit Rev Oncol Hematol; 2014 Aug; 91(2):113-22. PubMed ID: 24629840
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the 5'-flanking region and regulation of transcription of human BAFF-R gene.
Yuan H; Wang Y; Wu X; Wang H; Pu J; Ding W; Wang M; Shen X; Cong H; Zhang L; Zhang M; Ju S
DNA Cell Biol; 2010 Mar; 29(3):133-9. PubMed ID: 20025535
[TBL] [Abstract][Full Text] [Related]
12. A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cells.
McClements M; Williams S; Ball C; Bristow A; Wadhwa M; Meager A
J Immunol Methods; 2008 Aug; 337(1):63-70. PubMed ID: 18625509
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of BAFF receptor, a member of the tumor necrosis factor receptor family, in malignant cells of nonhematopoietic origins.
Kohno T; Daa T; Otani H; Shimokawa I; Yokoyama S; Matsuyama T
Genes Cells; 2008 Oct; 13(10):1061-73. PubMed ID: 18775026
[TBL] [Abstract][Full Text] [Related]
14. The effects of Jieduquyuzishen prescription-treated rat serum on the BAFF/BAFF-R signal pathway.
Wu DH; Xu L; Wen CP; Xie GQ; Ji JJ; Pan JL; Jiao YF; Fan YS
PLoS One; 2015; 10(2):e0118462. PubMed ID: 25689512
[TBL] [Abstract][Full Text] [Related]
15. Non-canonical NF-κB Plays a Pivotal Role in Non-Hodgkin's Lymphoma.
Liu M; Song W; Zhang J; Sun M; Sun X; Yu Q
Cell Biochem Biophys; 2015 Jul; 72(3):681-5. PubMed ID: 27352187
[TBL] [Abstract][Full Text] [Related]
16. Requirement for BAFF and APRIL during B cell development in GALT.
Yeramilli VA; Knight KL
J Immunol; 2010 May; 184(10):5527-36. PubMed ID: 20400696
[TBL] [Abstract][Full Text] [Related]
17. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
[TBL] [Abstract][Full Text] [Related]
18. BAFF promotes proliferation of human mesangial cells through interaction with BAFF-R.
Zheng N; Wang D; Ming H; Zhang H; Yu X
BMC Nephrol; 2015 May; 16():72. PubMed ID: 25975951
[TBL] [Abstract][Full Text] [Related]
19. TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia.
Fazio G; Turazzi N; Cazzaniga V; Kreuzaler M; Maglia O; Magnani CF; Biagi E; Rolink A; Biondi A; Cazzaniga G
Br J Haematol; 2018 Aug; 182(3):434-436. PubMed ID: 28573703
[No Abstract] [Full Text] [Related]
20. B-cell-activating factor inhibits CD20-mediated and B-cell receptor-mediated apoptosis in human B cells.
Saito Y; Miyagawa Y; Onda K; Nakajima H; Sato B; Horiuchi Y; Okita H; Katagiri YU; Saito M; Shimizu T; Fujimoto J; Kiyokawa N
Immunology; 2008 Dec; 125(4):570-90. PubMed ID: 18540961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
